|
Trial no.:
|
PACTR201811891872703 |
Date of Registration:
|
27/11/2018 |
|
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
| TRIAL DESCRIPTION |
|
Public title
|
Multifidus cervicis plane (MCP) block versus Inter-Semispinal Plane (ISP) block for cervical spine surgery |
| Official scientific title |
Feasibility and efficacy of Multifidus cervicis plane (MCP) block versus Inter-Semispinal Plane (ISP) block for postoperative analgesia following cervical spine surgery; a prospective randomized trial |
|
Brief summary describing the background
and objectives of the trial
|
Posterior cervical spinal surgery is frequently associated with significant postoperative pain. Postoperative pain hinders early mobilization and rehabilitation and contributes to patient morbidity. 1
Many analgesic regimens have been evaluated to relieve such pain. Opioids analgesics have been documented to increase the risk of respiratory depression. Nonsteroidal anti-inflammatory drugs (NSAIDs) are frequently used as first-line treatment for acute pain after spine surgery but may provide inadequate analgesia. In addition, high doses of NSAIDs have also been implicated for nonunion in spine fusion surgeries. 2,3
The multifidus cervicis plane (MCP) block involves local anesthetic injection between the fascial plane of the multifidus cervicis and semispinalis cervicis muscles. 4
The inter-semispinal plane (ISP) block is a novel ultrasound-guided technique that involves local anesthetic injection into the fascial plane between the semispinalis cervicis and semispinalis capitis muscles.5
The aim of this study is to evaluate the feasibility and efficiency of multifidus cervicis plane (MCP) block versus inter-semispinal Plane (ISP) block for postoperative analgesia in patients undergoing cervical spine surgery.
|
| Type of trial |
RCT |
| Acronym (If the trial has an acronym then please provide) |
|
| Disease(s) or condition(s) being studied |
cervical spine surgery |
| Sub-Disease(s) or condition(s) being studied |
|
| Purpose of the trial |
Treatment: Other |
| Anticipated trial start date |
01/12/2018 |
| Actual trial start date |
03/01/2019 |
| Anticipated date of last follow up |
01/06/2019 |
| Actual Last follow-up date |
|
| Anticipated target sample size (number of participants) |
60 |
| Actual target sample size (number of participants) |
|
| Recruitment status |
Recruiting |
| Publication URL |
|
|